Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Relationship between Myeloperoxidase and Executive Function in Mild Vascular Cognitive Impairment
FY 2019-20
Summary
"As people age, they may develop difficulties in remembering things, thinking quickly and clearly, and carrying out important tasks. Injury to the blood vessels such as in coronary artery disease (CAD) puts you at a risk of developing these thinking difficulties. The condition involving a small decline in thinking abilities after an injury to one's blood vessels is called mild vascular cognitive impairment (mVCI). Research has suggested that a build up of toxic chemicals in the blood, produced by the immune system which protects the body against harmful germs and bacteria, can also harm blood vessels and in turn, brain function. Immune cells called neutrophils secrete a molecule called myeloperoxidase (MPO), which has been found in high concentrations in the blood of people with CAD and diseases involving severe forms of thinking difficulties like dementia. Importantly, this relationship has not been tested in earlier stages of disease, like mVCI, where intervention may have a big impact. In this study, I want to measure the amount of MPO in the blood of those with mVCI and see if it is related to their ability to think. Thinking abilities will be measured using validated tests involving problem-solving, puzzles and ""connect-the-dots"". I propose that higher MPO in the blood will be associated with more difficulty in thinking quickly and clearly in patients with mVCI. This research will allow us to better understand mVCI in order to develop medications that can stop it. Thinking difficulties increase risk of hospitalization and mortality, and adversely affects quality of life and ability to perform daily activities. Currently there is no treatment for mVCI. Targeting this decline in earlier stages can help us stop its progression into more severe disorders like dementia."
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
428705
Name
Bawa Kritleen K
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Relationship between Myeloperoxidase and Executive Function in Mild Vascular Cognitive Impairment
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cognitive Decline; Coronary Artery Disease; Dementia; Executive Function; Inflammation; Mild Vascular Cognitive Impairment; Myeloperoxidase; Oxidative Stress; Peripheral Marker; Vascular Dysfunction
Abstract
"As people age, they may develop difficulties in remembering things, thinking quickly and clearly, and carrying out important tasks. Injury to the blood vessels such as in coronary artery disease (CAD) puts you at a risk of developing these thinking difficulties. The condition involving a small decline in thinking abilities after an injury to one's blood vessels is called mild vascular cognitive impairment (mVCI). Research has suggested that a build up of toxic chemicals in the blood, produced by the immune system which protects the body against harmful germs and bacteria, can also harm blood vessels and in turn, brain function. Immune cells called neutrophils secrete a molecule called myeloperoxidase (MPO), which has been found in high concentrations in the blood of people with CAD and diseases involving severe forms of thinking difficulties like dementia. Importantly, this relationship has not been tested in earlier stages of disease, like mVCI, where intervention may have a big impact. In this study, I want to measure the amount of MPO in the blood of those with mVCI and see if it is related to their ability to think. Thinking abilities will be measured using validated tests involving problem-solving, puzzles and ""connect-the-dots"". I propose that higher MPO in the blood will be associated with more difficulty in thinking quickly and clearly in patients with mVCI. This research will allow us to better understand mVCI in order to develop medications that can stop it. Thinking difficulties increase risk of hospitalization and mortality, and adversely affects quality of life and ability to perform daily activities. Currently there is no treatment for mVCI. Targeting this decline in earlier stages can help us stop its progression into more severe disorders like dementia."
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Bawa, Kritleen K
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~